Cervix Cancer

Cancer Screening: Theory and Practice

Volumn , Issue , 2021, Pages 195-217

  Miller, Anthony B ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85130911259     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9780429179587-12     Document Type: Chapter

References (64)

1. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54:594-606.
2. Beral V, Hermon C, Munoz N, Devesa SS. Cervical cancer. Cancer Surv 1994; 19-20: 265-285.
3. Coleman M, Esteve J, Damiecki P, Arsian A, Renard H. Time Trends in Cancer Incidence and Mortality [IARC Scientific Publication No. 121]. Lyon, International Agency for Research on Cancer, 1995.
4. Kosary CL, Reis LAG, Miller BA, Hankey BF, Harras A, Edwards B K, eds. SEER Cancer Statistics Review, 1973-1992: Tables and Graphs. [NIH Publication No. 96-2789]. Bethesda, MD: National Cancer Institute, 1995.
5. Larsen NS. Invasive cervical cancer rising in young white females [News item]. J Natl Cancer Inst 1994; 86:6-7.
6. Ponten J, Adami HO, Bergstrom R, Dillner J, Friberg LG, Gustafsson L, Miller A B, Parkin DM, Sparen P, Trichopoulos D. Strategies for global control of cervical cancer. Int J Cancer 1995; 60:1-26.
7. Tomatis L, Aitio A, Day NE. Heseltine E, Kaldor J, Miller AB, Parkin DM, Riboli E, eds. Cancer: Causes, Occurrence and Control [IARC Scientific Publication No. 100]. Lyon: International Agency for Research on Cancer, 1990.
8. IARC monographs on the evaluation of the carcinogenic risks to humans. Vol. 64. Human Papillomaviruses. Lyon: International Agency for Research on Cancer, 1995.
9. Hakama M. Trends in the incidence of cervical cancer in the Nordic countries. In: Magnus K, ed. Trends in Cancer Incidence, Causes and Practical Implications. New York: Hemisphere Publishing Corp, 1982: 279-292.
10. National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. JAMA 1989; 262:931-934.
11. Kinlen LJ, Spriggs AI. Women with positive cervical smears but without surgical intervention. Lancet 1978; ii:463-465.
12. Boyes DA, Morrison B, Knox EG, Draper G, Miller AB. A cohort study of cervical cancer screening in British Columbia. Clin Invest Med 1982; 5:1-29.
13. IARC Working Group on Cervical Cancer Screening. Summary chapter. In: Hakama M, Miller AB, Day NE, eds. Screening for Cancer of the Uterine Cervix [IARC Scientific Publications No. 76]. Lyon: International Agency for Research on Cancer, 1986: 133-142.
14. Miller AB, Anderson G, Brisson J, Laidlaw J, Le Pitre N, Malcolmson P, Mirwaldt P, Stuart G, Sullivan W. Report of a National Workshop on Screening for Cancer of the Cervix Can Med Assoc J 1991; 145:1301-1325.
15. Hakama M, Chamberlain J, Day NE, Miller AB, Prorok PC. Evaluation of screening programmes for gynaecological cancer. Br J Cancer 1985; 52:669-673.
16. Task Force. Cervical Cancer Screening Programs. The Walton Report. Can Med Assoc J 1976; 114:1003-1033.
17. Chamberlain J. Reasons that some screening programmes fail to control cervical cancer. In: Hakama M, Miller AB, Day NE, eds. Screening for Cancer of the Uterine Cervix [IARC Scientific Publications No. 76]. Lyon: International Agency for Research on Cancer, 1986: 161-168.
18. Gustafsson L, Sparen P, Gustafsson M, Petersson B, Wilander E, Bergstrom R, Adami HO. Low efficiency of cytologic screening for cancer in situ of the cervix in older women. Int J Cancer 1995; 63:804-809.
19. Miller AB, Knight J, Narod S. The natural history of cancer of the cervix, and the implications for screening policy. In: Miller AB, et al, eds. Cancer screening. Cambridge, Cambridge University Press, 1991: 144-152.
20. Morrison BJ, Coldman AJ, Boyes DA, Anderson GH. Forty years of repeated screening: the significance of carcinoma in situ. Br J Cancer 1996; 74:814-819.
21. Holowaty PH. The Natural History of Cervical Dysplasia. Ph.D. thesis, University of Toronto, Toronto, Canada, 1996.
22. van Oortmarssen GJ, Habbema, JDF. Duration of preclinical cervical cancer and reduction in incidence of invasive cancer following negative Pap smears. Int J Epidemiol 1995; 24:300-307.
23. Stjernswärd J. National training of radiotherapists in Sri Lanka and Zimbabwe: priorities and strategies for cancer control in developing countries. Int J Radiat Oncol Biol Phys 1990; 19:1275-1278.
24. Stjernswärd J, Eddy D, Luthra U, Stanley K. Plotting a new course for cervical cancer screening in developing countries. World Health Forum 1987; 8:42-45.
25. Seghal A, Singh V, Bhampani S, Luthra UK. Screening for cervical cancer by direct inspection. Lancet 1991; i:282.
26. Singh V, Seghal A, Luthra UK. Screening for cervical cancer by direct inspection. BMJ 1992; 304:534-535.
27. Nene BM, Deshpande S, Jayant K, Buduki AM, Dale PS, Deshpande DA, Chiwate AS, Malvi SG, Deokar S, Parkin DM, Sankaranarayanan R. Early detection of cervical cancer by visual inspection: a population-based study in rural India. Int J Cancer 1996; 68:770-773.
28. Wesley R, Sankaranarayanan R, Mathew B, Cahandralekha B, Beegum AA, Amma NS, Nair MK. Evaluation of visual inspection as a screening test for cervical cancer. Br J Cancer 1997; 75:436-440.
29. Szarewski A, Cuzick J, Edwards R, Butler B, Singer A. The use of cervicography as a primary screening service. Br J Obstet Gynaecol 1991; 98:313-317.
30. Tawa K, Forsythe A, Cove JK, et al. A comparison of the Papanicolaou smear and the cervigram: sensitivity, specificity and cost analysis. Obstet Gynecol 1988; 71:299-235.
31. Lundin FE, Christopherson WM, Mendez WM, Parker JE. Morbidity from cervical cancer. Effects of cervical cytology and socio-economic status. J Natl Cancer Inst 1965; 35:1015-1025.
32. Hill GB, Adelstein AM. Cohort mortality from carcinoma of the cervix. Lancet 1967; ii: 605-606.
33. Burns EL, Hammond EC, Percy C, Seidman H, Gorski TW. Detection of uterine cancer. Results of a community program of 17 years. Cancer 1968; 22:1108-1119.
34. Christopherson WM, Parker JE, Mendez WM, Lundin FE. Cervix cancer death rates and mass cytologic screening. Cancer 1970; 26:808-811.
35. Higgins ITT. Recent mortality from cancer of the cervix in the United States and United Kingdom. Lancet 1971; ii: 1141-1143.
36. Dickinson L, Mussey ME, Soule EH, et al. Evaluation of the effectiveness of cytologic screening for cervical cancer I. Incidence and mortality trends in relation to screening. Mayo Clin Proc 1972; 47:534-544.
37. Kinlen LJ, Doll R. Trends in mortality from cancer of the uterus in Canada and in England and Wales. Br J Prev Soc Med 1973; 27:146-149.
38. Christopherson WM, Lundin FE, Mendez WM, Parker J. Cervical cancer control. A study of morbidity and mortality trends over a twenty-one year period. Cancer 1976; 38:1357-1366.
39. Johanneson G, Geirsson G, Day N. The effect of mass screening in Iceland, 1965-1974, on the incidence and mortality of cervical carcinoma. Int J Cancer 1978; 21:418-425.
40. MacGregor JE, Teper S. Mortality from cancer of the cervix uteri in Britain. Lancet 1978; ii:774-776.
41. Draper GJ, Cook GA. Changing patterns of cervical cancer rates. BMJ 1983; 287:510-512.
42. Lynge E, Madsen M, Engholm G. Effect of organized screening on incidence and mortality of cervical cancer in Denmark. Cancer Res 1989; 49:2157-2160.
43. Parkin DM, Nguyen-Dinh X, Day NE. The impact of screening on the incidence of cervical cancer in England and Wales. Br J Obstet Gynaecol 1985; 92:150-157.
44. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes. Lancet 1987; i: 1247-1249.
45. Cramer DW. The role of cervical cytology in the declining morbidity and mortality of cervical cancer. Cancer 1974; 34:2018-2027.
46. Miller AB, Lindsay J, Hill GB. Mortality from cancer of the uterus in Canada and its relationship to screening for cancer of the cervix. Int J Cancer 1976; 17:602-612.
47. Miller AB, Visentin T, Howe GR. The effect of hysterectomies and screening on mortality from cancer of the uterus in Canada. Int J Cancer 1981; 27:651-657.
48. Clarke EA, Anderson TW. Does screening by “Pap” smears help prevent cervical cancer? Lancet 1979; ii:l-4.
49. Aristizabal N, Cuello C, Correa P, Collazos T, Haenszel W. The impact of vaginal cytology on cervical cancer risks in Cali, Columbia. Int J Cancer 1984; 34:5-9.
50. Raymond L, Obradovic M, Riotton G. A case-control study to evaluate cytological screening of cervical cancer. Rev Epidemiol Santé pubi 1984; 32:10-15.
51. MacGregor JE, Moss SM, Parkin DM, Day NE. A case control study of cervical screening in North East Scotland. BMJ 1985; 290:1543-1548.
52. Benino F, Gatta G, D’Alto M, Crosignani P. Efficacy of screening in preventing invasive cervical cancer: a case-control study in Milan, Italy. In: Hakama M, Miller AB, Day NE, eds. Screening for Cancer of the Uterine Cervix [IARC Scientific Publications No. 76]. Lyon: International Agency for Research on Cancer, 1986: 111-123.
53. Van der Graaf Y, Zielhuis GA, Peer PG, Vooijs PG. The effectiveness of cervical screening: a population-based case-control study. J Clin Epidemiol 1988; 41:21-26.
54. Prorok PC, Chamberlain J, Day NE, Hakama M, Miller AB. UICC workshop on the evaluation of screening programmes for cancer. Int J Cancer 1984; 34:1-4.
55. Morrison AS. Screening in chronic disease. Oxford: Oxford University Press, 1985: 102.
56. Sasco AJ, Day NE, Walter SD. Case-control studies for the evaluation of screening. J Chron Dis 1986; 39:399-405.
57. Eddy D. Screening for Cancer: Theory, Analysis, and Design. Englewood Cliffs, NJ: Prentice-Hall, 1980.
58. Muller C, Mandelblatt J, Schechter CB, Power EJ, Duffy BM, Wagner JL. Costs and effectiveness of cervical cancer screening in elderly women-background paper. US Congress, Office of Technology Assessment [OTA-BP-H-65]. Washington, DC: US Government Printing Office, 1990.
59. Walton RJ, Allen HH, Anderson GH, Boyes DA, Blanchet M, Carmichael J, Gell-man DD, Hill GB, Miller AB, Thomson DW, Kassierer E. Cervical cancer screening programmes: summary of the 1982 Canadian Task Force Report. CMA Journal 1982; 127:581-589.
60. American Cancer Society. Guidelines for the cancer-related check-up. Recommendations and rationale. CA 1980; 30:193-240.
61. Fink DJ. Change in American Cancer Society checkup guidelines for early detection of cervical cancer. CA 1988; 38:127-128.
62. Mettlin C, Dodd GD. The American Cancer Society guidelines for the cancer-related checkup: an update. CA 1991; 41:279-282.
63. Report of the U.S. Preventive Services Task Force. Guide to Clinical Preventative Services. 2d ed. Washington, DC: U.S. Department of Health and Human Services, 1996.
64. Miller AB. Editorial: failures of cervical cancer screening. Am J Public Health 1995; 85:761-762.